Ongoing Research Projects

Ongoing COVID19 Research Projects

SN Title of Research Department
1 Association of The Prophylactic Measures Adopted With The Severity Of Disease In The Confirmed Cases Of COVID-19 In Police of Nashik District : An Observational Study Physiology
2 An Epidemiological Study to Identify the Socio-Demographic Determinants of COVID 19 Infection And Recommend Interventional Strategies Community Medicine
3 Comparative Study of Various Biochemical Parameters in COVID-19 Positive Patients – Stage I Biochemistry
4 Study Of Pulse Rate, Oxygen Saturation And Respiratory Rate In Progression Of Covid-19 Disease – An Observational Study Anesthesiology
5 A Cross Sectional Study of Psychological Impact of Covid-19 Pandemic among Healthcare Workers in India Psychiatry
6 C-Reactive Protein (CRP) And Serum Ferritin Levels as a Prognostics Indicator in Indian COVID-19 Positive Cases Admitted in ICU at Tertiary Care Unit General Medicine
7 Study of Asymptomatic Urinary Abnormalities in COVID-19 Positive Patients Admitted to a Tertiary Care Hospital General Medicine
8 Study of Prothrombotic Parameters as Markers of Severity in COVID-19 Positive Patients Admitted to a Tertiary Care Hospital General Medicine
9 Perception of Medical Undergraduate students towards Online Education during COVID19 pandemic Physiology, Community Medicine, Pharmacology


Ongoing Clinical Trials

Sr. No Name of  trial Study Code/ Number Principal Investigator Department Sponsor Status & Year
1 A phase IV, prospective, multi-centric, double-blind, comparative, clinical study to compare the efficacy and safety of intravenous ulinastatin versus placebo along with standard supportive care in subjects with severe sepsis. BSV-UTI-IV-614 Dr. Neelima Chafekar Medicine Bharat Serums & Vaccines Limited Ongoing 2016
2 A Multicentric, Randomized, Prospective,Open Label, Comparative,Parallel Group Clinical Trial to Evaluate the Efficacy and Safety of Fixeddose combination of Trypsin – Chymotrypsin Enzyme and Diclofenac Oral Tablet in comparison with Diclofenac oral Tablet in the management of acute inflammation due to soft tissue injuries. CT/TRYP+CHYM+DICL/STI//15 PI-Dr.Sudhir Bhamre



Surgery Torrent  pharmaceuticals Ltd. Ongoing 2017
3 A Prospective, Multicenter, Randomized, Double-Blind, Phase 3 Study to Evaluate the Safety and Efficacy ofa Gel Formulation of Esmolol Hydrochloride (Galnobax@) in Treating Diabetic Foot Ulcers. NG-A16 PI-Dr.Sudhir Bhamre


Surgery JSS Medical Research India Private Ltd Monitoring (Novalead Pharma) Ongoing 2019
4 Safety and Efficacy of Transarterial Chemoembolization with Lipiodol® in the treatment of inoperable Hepatocellular Carcinoma (HCC) in Indian Patients. LUF-44-005 PI-Dr. Soham Doshi


Medicine Guerbet medical expert Ongoing 2020
5 A Multicentric, Randomized, Open Label, Parallel group, Comparative Controlled Phase III Trial to evaluate the Efficacy and Safety of Fixed Dose Combination of Bisoprolol 2.5 mg / 5 mg and Telmisartan 40 mg / 40 mg tablet in subjects with mild to moderate hypertension. PI:Dr Sandip Chaudhary


Medicine In process 2021
6 A Multicenter, Prospective, Randomized, Double Blind, Parallel groupPlacebo Controlled Clinical End Point study of Ozenoxacin topical cream 1% in malesand non Pregnant, non lactating females with Impetigo. Dr. V.P Zawar Dermatology In process 2021
7 A Phase III, Prospective, Randomized, Open-label, Parallel-group,Multicenter Clinical Trial to Compare the Efficacy and Safety of Single-pill Fixed dosecombination of Dapagliflozin plus Teneligliptin (10 mg + 20 mg) versus Teneligliptin20 mg in Treatment of Patients with Inadequately Controlled Type 2 Diabetes Mellitus Dr. Sandip Chaudhari Medicine In process 2021
8 A randomized, double blind, multicentric, placebo controlled, parallel group clinical trial to evaluate the efficacy and safety of Plecanatide in subjects with chronic idiopathic constipation or irritable bowel syndrome with constipation Dr.Madhuri Kirloskar Medicine M/s.MSN Laboratories Private Limited In process 2021
9 A randomized, double blind, placebo-contro Iled study to evaluate safety and efficacy ofIP with Standard ofCare (SOC) vs. Placebo with SOC in hospitalized patients with severe COVID-19. SE/2IO4O IAJM/COVID Dr. Mayur Devraj TB &Chest Vedic Lifesciences In process 2021
10 A randomized, open label, two arm, multicenter, prospective, clinical study to evaluate efficacy and safety of HRPT-091514 as an adjuvant to standard of care in subjects with chronic kidney disease. Interventional Dr.Abhijit More Medicine Himalaya In process 2022